Intrapartum antibiotics and childhood atopic dermatitis

Debra L Wohl1, William J Curry2, Dave Mauger2

  • 1From the Department of Biology, Elizabethtown College, Elizabethtown, PA (DLW); the Department of Family and Community Medicine, Penn State Milton S. Hershey Medical Center, Hershey, PA (WJC); the Department of Public Health Sciences, Pennsylvania State University College of Medicine, Hershey (WJC, DM); the Department of Pediatrics, Penn State Milton S. Hershey Medical Center and Pennsylvania State University College of Medicine, Hershey (JM); and the Pennsylvania State University College of Medicine, Hershey (KT). wohld@etown.edu.

Insights

Intrapartum antibiotic exposure for less than 24 hours during vaginal delivery does not increase a child's risk of atopic dermatitis (AD). Longer exposure may increase AD risk, warranting further study.

Area of Science:

  • Pediatrics
  • Neonatal Care
  • Dermatology

Background:

  • Atopic dermatitis (AD) significantly impacts children and families, causing medical costs and associated conditions like asthma.
  • Investigating the link between intrapartum antibiotic exposure and early-onset AD in infants is crucial.

Purpose of the Study:

  • To determine if infants born vaginally to mothers receiving intrapartum antibiotics have a higher risk of developing AD before age 2.
  • To identify risk factors associated with AD development in early childhood.

Main Methods:

  • Retrospective analysis of 492 mother-child pairs who delivered vaginally between 1996 and 2008.
  • Categorization of mothers based on intrapartum antibiotic administration.
  • Utilizing pediatric records to ascertain AD incidence by age 2.

Main Results:

  • No increased risk of AD was observed for children exposed to intrapartum antibiotics for less than 24 hours.
  • Intrapartum antibiotic exposure exceeding 24 hours was associated with a higher risk of AD (RR, 1.99).
  • Being a firstborn infant and higher maternal education were also linked to increased AD risk.

Conclusions:

  • Short-term intrapartum antibiotic exposure (<24 hours) during vaginal delivery does not elevate the risk of atopic dermatitis.
  • Further research is necessary to elucidate the potential increased risk of AD associated with prolonged intrapartum antibiotic exposure (>24 hours).
Abstract

Related Concept Videos

Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
75
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
61
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
110
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
50
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
46
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
6.3K